Becker's Hospital Review | Healthcare News & Analysis

Author's posts

New Hampshire system names revenue cycle VP

Berlin, N.H.-based North Country Healthcare has named Patrick Curtin vice president of revenue cycle. 

Health systems execs revitalize the nursing workforce

Many hospitals and health systems saw a large number of nurse exits during the pandemic, either to join travel agencies, retire or leave the healthcare industry altogether.

Public payer-provider fights increase nearly 70%

Contract negotiation disputes between payers and providers that were reported in the media increased 69% between 2022 and 2023, and the number of communities affected across the country grew as well, according to data published Jan. 16 by FTI Consultin…

Endeavor to pay $55M to resolve antitrust allegations

Evanston, Ill.-based Endeavor Health, formerly known as NorthShore – Edward-Elmhurst Health, has agreed to pay a $55 million all-cash settlement to resolve antitrust allegations raised after NorthShore’s acquisition of Highland Park Hospital, a competi…

Safety, recruiting, care access: Hospital COOs bring 2024 into focus

COOs are often tasked with overseeing the daily overall operations at hospitals and health systems. However, their role tends to vary depending on the organization, and they are focused on an array of issues. But one issue appears to be top of mind for…

The nonprofit teaming up with Mayo on AI transparency

Academic hospitals and technology firms are a part of a nonprofit that is setting out to establish a network of laboratories across the country to test healthcare artificial intelligence tools. 

What's a 'Midwestern' health system, anyway?

A dozen states make up the Midwest, but many more Americans in neighboring states think they, too, are part of the region. 

Children's National Hospital taps Clearway to deliver $2.8M gene therapy

Washington, D.C.-based Children’s National Hospital administered Zynteglo, a $2.8 million gene therapy, to its first pediatric patient with the help of Clearway Health. 

FDA adds severe risk warning to bone disease drug

The bone disease drug Prolia has a new boxed warning, the FDA’s most prominent warning, because of an increased risk of severe hypocalcemia among chronic kidney disease patients. 

Takeaways from Penn Medicine's AI conference

AI will revolutionize every aspect of healthcare, including drug, medical device, and medical software regulation; clinical education and more, according to three panelists at a Jan. 12 forum hosted by Philadelphia-based University of Pennsylvania’s Le…